Clinical Outcomes of Acute Leukemia in Children Less Than 2 Years: Experience from a Tertiary Center in Thailand
Open Access
- 28 February 2025
- journal article
- Published by Faculty of Medicine Prince of Songkla University in Journal of Health Science and Medical Research
- p. 20251163
Abstract
Objective: This study aimed to examine the prognostic factors and treatment outcomes of patients with acute leukemia aged under 2 years. Material and methods: The medical records of acute leukemia patients aged under 2 between January 1979 and December 2021 were retrospectively reviewed. The Kaplan-Meier method was used to calculate the event-free survival (EFS) and overall survival (OS) rates. A univariate Cox proportional hazards regression model was used to identify clinical factors associated with poor EFS and OS. A p-value<0.05 was considered statistically significant.Results: Over the 43-year study period, 137 children with acute leukemia aged under 2 years of age were identified. Of these, 70 (51.1%) had acute lymphoblastic leukemia (ALL) and 67 (48.9%) had acute myeloid leukemia (AML). After induction, 89.1% of ALL patients achieved complete remission, with an induction death rate of 3.2%. The 5-year OS and EFS rates were 46.0% and 41.0%, respectively. After induction, 44.8% of the AML patients achieved complete remission, with an induction death rate of 29.3%. The 5-year OS and EFS rates in this group were 10.0% and 9.0%, respectively. No significant prognostic factors were identified to predict survival outcomes in children with AML under 2 years. Conclusion: Both ALL and AML childhood leukemia patients aged under 2 years had poor survival outcomes.Keywords
This publication has 28 references indexed in Scilit:
- Prevalence and risk factors of disseminated intravascular coagulation in childhood acute lymphoblastic leukemiaPediatric Research, 2023
- Intensified chemotherapy without SCT in infant ALL: Results from COG P9407 (Cohort 3)Pediatric Blood & Cancer, 2014
- Favorable outcome in infants with AML after intensive first- and second-line treatment: an AML-BFM study group reportLeukemia, 2011
- Long-term results of the pediatric oncology group studies for childhood acute lymphoblastic leukemia 1984–2001: a report from the children's oncology groupLeukemia, 2009
- Cancer chemotherapy in young children: Challenges and solutionsPediatric Blood & Cancer, 2007
- A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trialThe Lancet, 2007
- A comparison of early intensive methotrexate/mercaptopurine with early intensive alternating combination chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group phase III randomized trialLeukemia, 2001
- Prognostic factors in infants with acute myeloid leukemiaLeukemia, 2000
- INTENSIVE THERAPY FOR CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKAEMIA AND UNFAVOURABLE PRESENTING FEATURESThe Lancet, 1988
- The staging of childhood acute lymphoblastic leukemia: Strategies of the childrens cancer study group and a three-dimensional technic of multivariate analysisMedical and Pediatric Oncology, 1986